Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rucaparib DDI with Rosuvastatin and Oral Contraceptives
NCT03954366Phase 1Completed
- Sponsor
- pharma&
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 1, open-label trial of rucaparib in solid tumor (advanced stage) (2 arms), sponsored by pharma&. Primary endpoint: PK parameters for oral rosuvastatin, ethinylestradiol and levonorgestrel without and with rucaparib treatment at Day 23. Started Apr 2019; status: completed.
02
Drugs
rucaparib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03954366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03954366.